Serum sphingolipidomic analyses reveal an upregulation of C16-ceramide and sphingosine-1-phosphate in hepatocellular carcinoma.
about
Sphingosine kinase-1, S1P transporter spinster homolog 2 and S1P2 mRNA expressions are increased in liver with advanced fibrosis in human.Sphingosine-1-phosphate induced epithelial-mesenchymal transition of hepatocellular carcinoma via an MMP-7/ syndecan-1/TGF-β autocrine loopTargeting the Metabolic Reprogramming That Controls Epithelial-to-Mesenchymal Transition in Aggressive Tumors.Sphingosine 1-Phosphate Signaling as a Target in Hepatic Fibrosis Therapy.The Role of Sphingosine-1-Phosphate and Ceramide-1-Phosphate in Inflammation and Cancer.Deletion of sphingosine kinase 1 inhibits liver tumorigenesis in diethylnitrosamine-treated mice.Divergent Role of Sphingosine 1-Phosphate in Liver Health and Disease.Preanalytical Biases in the Measurement of Human Blood Sphingolipids.Low Serum Levels of (Dihydro-)Ceramides Reflect Liver Graft Dysfunction in a Real-World Cohort of Patients Post Liver Transplantation.Ceramide species are elevated in human breast cancer and are associated with less aggressiveness.
P2860
Q37208958-90D12508-F101-4295-B8F4-93DF010395F7Q37665322-668C3D23-B4FB-47A0-9318-28418DFF3F86Q39205930-EECC2F02-4906-41F6-A2CC-669F6E0C081FQ41547434-619DF795-9A18-48B6-B990-CA8CDF4780C8Q47130227-B20358DA-9E45-43D1-B9F4-9D499C57C87CQ52592866-D7EE1A34-4BFE-4AB9-83D4-ED2705E383EDQ52671501-23F71A01-1024-4FEE-ADB3-74A2AAE6F740Q53284180-0BDCB6D2-1209-4B0C-A716-5DE1D7F7C741Q54963944-3B6014F9-08FC-4291-AC2A-BEB5D8BA9367Q55002300-8A9289DB-89E2-4AA1-9950-728F002C0DF1
P2860
Serum sphingolipidomic analyses reveal an upregulation of C16-ceramide and sphingosine-1-phosphate in hepatocellular carcinoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 February 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Serum sphingolipidomic analyse ...... e in hepatocellular carcinoma.
@en
Serum sphingolipidomic analyse ...... e in hepatocellular carcinoma.
@nl
type
label
Serum sphingolipidomic analyse ...... e in hepatocellular carcinoma.
@en
Serum sphingolipidomic analyse ...... e in hepatocellular carcinoma.
@nl
prefLabel
Serum sphingolipidomic analyse ...... e in hepatocellular carcinoma.
@en
Serum sphingolipidomic analyse ...... e in hepatocellular carcinoma.
@nl
P2093
P2860
P356
P1433
P1476
Serum sphingolipidomic analyse ...... e in hepatocellular carcinoma.
@en
P2093
Bernd Kronenberger
Dimitra Bon
Eva Herrmann
Georgios Grammatikos
Harald Farnik
Josef Pfeilschifter
Nerea Ferreirós
Niklas Schoell
Oliver Waidmann
Verena Köberle
P2860
P304
18095-18105
P356
10.18632/ONCOTARGET.7741
P407
P577
2016-02-26T00:00:00Z